Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
UPLOAD

UPLOAD

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
D
Other
View HTML
S-3

Simplified registration form

Registration Statements
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
POS EX

POS EX    

Registration Statements
View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML